Symbol Name ID |
Sh2d1b2
SH2 domain containing 1B2 MGI:3622649 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt involves: BALB/cJ |
decreased interferon-gamma secretion | J:166054 |
impaired natural killer cell mediated cytotoxicity | J:166054 | |
Sh2d1b2tm1.1Cpt/Sh2d1b2tm1.1Cpt involves: BALB/cJ * C57BL/6 |
impaired natural killer cell mediated cytotoxicity | J:166054 |
Sh2d1b2tm1Vei/Sh2d1b2tm1Vei involves: 129S1/Sv * 129X1/SvJ |
impaired natural killer cell mediated cytotoxicity | J:145969 |
increased natural killer cell mediated cytotoxicity | J:110195 | |
Tg(CD2-Sh2d1b2)#Vei/0 B6.Cg-Tg(CD2-Sh2d1b2)#Vei |
impaired natural killer cell mediated cytotoxicity | J:110195 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|